FDA approves only vaccine Penbraya for treatment of meningococcal disease in adolescents
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
The products will be manufactured at the company's facility in Bengaluru
Sets price band at ?695 to ?735 per Equity Share
The approval bolsters the company's Mycophenolate Mofetil portfolio
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated